Welcome to the genomic era.

1. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999;353:1083-91. 2. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999;10:1136-44. 3. Magee CC, Premkumar R, Jarcho JJ, Denton MD. High prevalence of hematologic markers of thrombotic microangiopathy in cardiac transplant recipients: relationship to renal function. Am J Transpl 2003;3:Suppl 5:196A. abstract. 4. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991; 2:Suppl 1:S45-S52. 5. Young EW, Ellis CN, Messana JM, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int 1994;46:1216-22. 6. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-40. 7. National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory Board. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification: Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002;39:Suppl 2:S1-S246. 8. Renal Data System. USRDS 2002 annual data report: atlas of end-stage renal disease in the United States. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 2002. (Also available at http://www.usrds.org.) 9. St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 2003;41:903-24. 10. Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000;343:404-10. 11. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346:580-90. 12. Pascual M, Curtis J, Delmonico F, et al. A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation 2003; 75:1501-5. 13. Tedoriya T, Keogh AM, Kusano K, et a. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation — potential role of mycophenolate mofetil. J Heart Lung Transplant 2002;21:976-82. 14. Soccal PM, Gasche Y, Favre H, Spiliopoulos A, Nicod LP. Improvement of drug-induced chronic renal failure in lung transplantation. Transplantation 1999;68:164-5. 15. Matthews JB, Ramos E, Bluestone JA. Clinical trials of transplant tolerance: slow but steady progress. Am J Transplant 2003;3:794-803. 16. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-72. [Erratum, JAMA 2003;290:197.] Copyright © 2003 Massachusetts Medical Society.